title: [Clinical analysis of 16 cases of invasive pulmonary aspergillosis in children].
abstract: OBJECTIVE
  To investigate the diagnosis and treatment of invasive pulmonary aspergillosis (IPA) in children.
  
  
  METHODS
  The clinical data of 16 cases of proven or probable IPA who had been in our Hospital from January 2006 to June 2014 were retrospectively analyzed.
  
  
  RESULTS
  Among the 16 patients, 11 were males and 5 were females. One child had proven IPA and 15 children had probable IPA. Host risk included long duration use of multiple broad-spectrum antibiotics in 16 cases, neutropenia in 9 cases, invasive mechanical ventilation in 3 cases, primary immunodeficiency disease in 2 cases, long-term use of glucocorticoids in 2 cases, measles in 2 cases, and congenital pulmonary hypoplasia in 1 case. Fever, cough and expectoration were present in all the children with IPA. At the time of diagnosis, the halo sign and subpleural wedge consolidation shadows were more common in neutropenia group (5/9, 7/9) than those in non-neutropenia group(0/7, 1/7)(P<0.05). The cavities and"air-crescent sign"were more common after 15 days to 1 month when the children had been treated with anti-aspergillosis drugs than that at the onset of diagnosis of IPA (P<0.05). The positive rate of serum galactomannan (GM) test was higher than that of sputum culture and serum G test (P<0.05). Thirteen children received voriconazole, in 7 of the children the treatment was effective.
  
  
  CONCLUSIONS
  Neutropenia were the common host risk factors in children with IPA. Subpleural wedge consolidation shadows, the halo sign and the"air-crescent"sign were highly suggestive of the diagnosis of IPA in children. Subpleural wedge consolidation shadows and the halo sign were more common in neutropenia group than in non-neutropenia group in the early stage of the course. Serum GM test played an important role in the diagnosis of IPA in children. Voriconazole was effective in majority of the children with IPA.
authors.affiliation: Department of Pediatrics, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Li
authors.forename: Guangmin
authors.initials: G
authors.lastname: Nong
authors.forename: Min
authors.initials: M
authors.lastname: Jiang
authors.forename: Jing
authors.initials: J
authors.lastname: Liu
authors.forename: Xiuan
authors.initials: X
authors.lastname: Liang
mesh_terms: D000900:Anti-Bacterial Agents; D001228:Aspergillosis; D002648:Child; D003371:Cough; D005260:Female; D005334:Fever; D005690:Galactose / Q000031:analogs & derivatives; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D008351:Mannans; D008457:Measles; D009503:Neutropenia; D012189:Retrospective Studies; D012307:Risk Factors; D013183:Sputum; D065819:Voriconazole
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D008351:Mannans; C012990:galactomannan; D065819:Voriconazole; D005690:Galactose